William Callahan
Directeur/Bestuurslid bij MEDISUN PRECISION MEDICINE LTD.
Actieve functies van William Callahan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MEDISUN PRECISION MEDICINE LTD. | Directeur/Bestuurslid | 01-07-2015 | - |
Independent Dir/Board Member | 01-07-2015 | - |
Loopbaan van William Callahan
Eerdere bekende functies van William Callahan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Operationeel Directeur | 19-11-2009 | 01-02-2012 |
TALPHERA, INC. | Corporate Officer/Principal | 01-03-2014 | - |
Opleiding van William Callahan
San Francisco State University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TALPHERA, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Medisun Precision Medicine Ltd.
Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
- Beurs
- Insiders
- William Callahan
- Ervaring